Aggressive NK cell leukaemia after splenectomy: Association with CD95-resistant memory T-cell proliferation and recalcitrant clinical course of haemophagocytic syndrome

European Journal of Haematology

Volumn 81, Issue 3, 2008, Pages 236-241

  Suzuki, Shinsuke ^a,b   Uozumi, Kimiharu ^a,b   Utsunomiya, Atae ^c   Ishitsuka, Kenji ^d   Masamoto, Izumi ^b   Owatari, Satsuki ^a   Makino, Torahiko ^c   White, Yohann ^b   Arima, Naomichi ^a,b  

^a KAGOSHIMA UNIVERSITY HOSPITAL   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c IMAMURA BUN IN HOSPITAL   (Japan)

^d FUKUOKA UNIVERSITY   (Japan)

Author keywords

Aggressive natural killer cell leukaemia; CD95 resistant T cell proliferation; Splenectomy

Indexed keywords

CD2 ANTIGEN; CD45RO ANTIGEN; CD8 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DOXORUBICIN; ETOPOSIDE; FAS ANTIGEN; HLA DR ANTIGEN; METHYLPREDNISOLONE; PREDNISONE; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; VINCRISTINE;

ADULT; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BIODIVERSITY; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER REGRESSION; CASE REPORT; CAUSE OF DEATH; CHROMOSOME ABERRATION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG MEGADOSE; DRUG TREATMENT FAILURE; EPSTEIN BARR VIRUS; FEMALE; HEMOPHAGOCYTIC SYNDROME; HUMAN; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE TREATMENT; JAPANESE; LEUKEMIA; LUNG HEMORRHAGE; LYMPHOCYTE PROLIFERATION; LYMPHOCYTOSIS; LYMPHOMA; MEMORY T LYMPHOCYTE; MOLECULAR CLONING; NATURAL KILLER CELL LEUKEMIA; PHENOTYPE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SPLEEN WEIGHT; SPLENECTOMY; SPLENOMEGALY;

ADULT; ANTIGENS, CD95; CELL PROLIFERATION; CHROMOSOME ABERRATIONS; DISEASE PROGRESSION; FATAL OUTCOME; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HUMANS; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE AGENTS; KARYOTYPING; KILLER CELLS, NATURAL; LEUKEMIA; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; RISK FACTORS; SPLENECTOMY;

EID: 49349109976     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2008.01097.x     Document Type: Article

References (17)

1. Byrne JA, Butler JL, Cooper MD. Differential activation requirements for virgin and memory T cells. J Immunol 1988 141: 3249 57.
2. Janka GE. Hemophagocytic syndromes. Blood Rev 2007 21: 245 53 (Review).
3. Chan JK, Jaffe ES, Ralfkiaer E. Extranodal NK/T-cell lymphoma, nasal type. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. Tumours of Haematopoietic and Lymphoid Tissues. World Health Organization Classification of Tumours. Lyon: IARC Press, 2001: 204 7.
4. Chan JK, Wong KF, Jaffe ES, Ralfkiaer E. Aggressive NK-cell leukaemia. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. Tumours of Haematopoietic and Lymphoid Tissues. World Health Organization Classification of Tumours. Lyon: IARC Press, 2001: 198 200.
5. Kwong YL, Chan AC, Liang R, Chiang AK, Chim CS, Chan TK, Todd D, Ho FC. CD56+ NK lymphomas: clinicopathological features and prognosis. Br J Haematol 1997 97: 821 9.
6. Suzuki R, Suzumiya J, Nakamura S, et al. NK-cell Tumor Study Group. Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells. Leukemia 2004 18: 763 70.
7. Imamura N, Kusunoki Y, Kawa-Ha K, et al. Aggressive natural killer cell leukaemia/lymphoma: report of four cases and review of the literature. Possible existence of a new clinical entity originating from the third lineage of lymphoid cells. Br J Haematol 1990 75: 49 59.
8. Wong KF. Genetic changes in natural killer cell neoplasms. Leuk Res 2002 26: 977 8.
9. Imashuku S, Obayashi M, Hosoi G, Sako M, Chen J, Mugishima H, Tsunamoto K, Hibi S, Todo S. Splenectomy in haemophagocytic lymphohistiocytosis: report of histopathological changes with CD19+ B-cell depletion and therapeutic results. Br J Haematol 2000 108: 505 10.
10. Loughran TP Jr., Starkebaum G, Clark E, Wallace P, Kadin ME. Evaluation of splenectomy in large granular lymphocyte leukaemia. Br J Haematol 1987 67: 135 40.
11. Kaizu K, Maeda M, Ohkawa T, Hayashida M, Nakajima S, Sugisaki Y, Fukunaga Y. Marked elevation of soluble fas ligand and cytokine secretion after splenectomy in aggressive natural killer cell leukemia/lymphoma. Leuk Lymphoma 2004 45: 2291 4.
12. Krammer PH. CD95's deadly mission in the immune system. Nature 2000 407: 789 95.
13. Fas SC, Baumann S, Krueger A, Frey CR, Schulze-Bergkamen H, Brenner D, Stumpf C, Kappes K, Krammer PH. In vitro generated human memory-like T cells are CD95 type II cells and resistant towards CD95-mediated apoptosis. Eur J Immunol 2006 36 : 2894 903.
14. Rogers PR, Dubey C, Swain SL. Qualitative changes accompany memory T cell generation: faster, more effective responses at lower doses of antigen. J Immunol 2000 164 : 2338 46.
15. Demeter J. Persistent lymphocytosis of natural killer cells after splenectomy. Br J Haematol 1995 91 : 253.
16. Ryder J, Wang X, Bao L, Gross SA, Hua F, Irons RD. Aggressive natural killer cell leukemia: report of a Chinese series and review of the literature. Int J Hematol 2007 85 : 18 25.
17. Kwong YL. Natural killer-cell malignancies: diagnosis and treatment. Leukemia 2005 19 : 2186 94. (Review).